Prostate cancer

  • Development of a global value dossier and value story slide set on chemotherapy naïve metastatic castration-resistant prostate cancer
  • Systematic literature reviews, abstract and poster development in prostate cancer
  • Steering committee meetings and manuscript on prostate cancer
  • US budget impact model in metastatic castration-resistant prostate cancer (mCRPC) and 10 country adaptations
  • Literature review of patient experience and treatment satisfaction in prostate cancer
  • Literature review to support validity and adequacy of the Functional Assessment of Cancer Therapy – Prostate (FACT-P), Brief Pain Inventory (BPI) and brief fatigue inventory (BFI) in prostate cancer
  • Literature and instrument review in castration-resistant prostate cancer
  • Literature review and consultancy on prostate cancer
  • Evaluation of content validity of the Cancer Therapy Satisfaction Questionnaire in prostate cancer
  • Manuscript on the evaluation of content validity of the Cancer Therapy Satisfaction Questionnaire in prostate cancer
  • Consultancy on the experience of M1 hormone naïve prostate cancer (mHNPC) patients on a specified chemotherapy drug
  • Articles for an endpoint review in BPI and FACT-P
  • Statistical analysis plan and analyses of the BPI using phase II data on the treatment of hormone-refractory prostate cancer
  • Development of an abstract and poster documenting the psychometric validation of the BPI-SF in castration-resistant prostate cancer patients
  • Strategic consulting for a PRO strategy in castration-resistant prostate cancer – scenario development for data interpretation
  • Publication strategy to support an evidence dossier in pain due to hormone-refractory prostate cancer and bone metastases
  • Investigation of PRO results for a phase III clinical trial in castration-resistant prostate cancer
  • Measurement strategy in prostate cancer
  • Post-hoc analysis of a phase III clinical trial in castration-resistant prostate cancer
  • PRO claim recommendations in pain related to bone metastases in hormone refractory prostate cancer

Related categories

Experience,  Oncology,  Therapeutic area